<DOC>
	<DOCNO>NCT01526174</DOCNO>
	<brief_summary>The investigator plan conduct open-label intratympanic injection proof-of-concept trial golimumab , TNF-alpha inhibitor , assess hearing loss progression patient autoimmune inner ear disease ( AIED ) . This specific aim achieve use two-arm approach . First , investigator propose dose 3 individual subject single intratympanic injection golimumab follow 30 day , closely examine adverse event . If serious adverse event , FDA approval , investigator propose dose 14 subject , 4 intratympanic injection golimumab .</brief_summary>
	<brief_title>Intratympanic Injection Autoimmune Inner Ear Disease</brief_title>
	<detailed_description />
	<mesh_term>Ear Diseases</mesh_term>
	<mesh_term>Labyrinth Diseases</mesh_term>
	<mesh_term>Labyrinthitis</mesh_term>
	<criteria>Diagnosis autoimmune inner ear disease ( AIED ) principal investigator Idiopathic , bilateral sensorineural hearing loss History , audiograms show , rapid progression hearing loss Bilateral loss least 30 dB one frequency ( 0.25 6 kHz ) Hearing responsive highdose oral steroid steroiddependent , determine history principal investigator . The subject take oral steroid , maintenance level , enrol First Arm , enrol Second Arm , begin taper first injection . Provided write informed consent participation clinical study Positive MRI vestibular schwannoma Positive FTA ( syphilis ) Significant middle ear disease ( e.g. , otitis medium ) Positive blood test Lyme disease Positive tuberculosis test Concurrent past treatment use medication and/or substance know cause ototoxicity ( example , aminoglycosides [ e.g. , gentamicin ] , cisplatin , loop diuretic , Yorgason et al. , 2006 ) Known adverse reaction golimumab , adalimumab , etanercept , infliximab , rituximab , ustekinumab , biologic immunomodulators Concurrent ( within past 3 month prior enrollment ) live viral intranasal vaccine ( flu ) Positive test HIV Positive test Hepatitis B C Presence demyelinate disease , multiple sclerosis Women childbearing potential : Positive serum pregnancy test prior only/first injection Active infection</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2013</verification_date>
	<keyword>autoimmune</keyword>
	<keyword>hearing loss</keyword>
	<keyword>bilateral hearing loss</keyword>
	<keyword>steroid-dependent</keyword>
</DOC>